Teachers Advisors’s Regulus Therapeutics RGLS Stock Holding History

Teachers Advisors’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-769	Closed	-$152K	–	3157
2017 Q1	$152K	Buy	769 +167	+28%	+$31.8K	﹤0.01%	2922
2016 Q4	$163K	Buy	602 +81	+16%	+$26.3K	﹤0.01%	2945
2016 Q3	$206K	Hold	521	–	–	﹤0.01%	2876
2016 Q2	$181K	Buy	521 +156	+43%	+$112K	﹤0.01%	2932
2016 Q1	$303K	Hold	365	–	–	﹤0.01%	2613
2015 Q4	$381K	Hold	365	–	–	﹤0.01%	2564
2015 Q3	$286K	Buy	365 +21	+6%	+$21.6K	﹤0.01%	2715
2015 Q2	$452K	Buy	344 +158	+85%	+$255K	﹤0.01%	2586
2015 Q1	$377K	Buy	186 +25	+16%	+$54.3K	﹤0.01%	2596
2014 Q4	$309K	Hold	161	–	–	﹤0.01%	2709
2014 Q3	$132K	Hold	161	–	–	﹤0.01%	3003
2014 Q2	$155K	Buy	161 +44	+38%	+$37.7K	﹤0.01%	2988
2014 Q1	$127K	Hold	117	–	–	﹤0.01%	3000
2013 Q4	$104K	Hold	117	–	–	﹤0.01%	3026
2013 Q3	$133K	Buy	117 +19	+19%	+$22.4K	﹤0.01%	2952
2013 Q2	$116K	Buy	+98	New	+$93.2K	﹤0.01%	2967

Other funds holding RGLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Teachers Advisors's RGLS Position: Q2 2017 in Review

Teachers Advisors sold out of Regulus Therapeutics (RGLS) in Q2 2017, closing a stake of 769 shares — an estimated $152K sold.

Teachers Advisors first reported a position in RGLS in Q2 2013 and held it in 16 quarters. The position peaked at $452K in Q2 2015. 46 funds tracked by Wall St. Rank hold RGLS as of Q2 2017.

Teachers Advisors reported no remaining Regulus Therapeutics position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 769 Regulus Therapeutics shares in Q2 2017, an estimated $152K.
Teachers Advisors first reported a position in Regulus Therapeutics in Q2 2013 and held it in 16 quarters.
Teachers Advisors's Regulus Therapeutics position peaked at $452K in Q2 2015.
46 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.